Nina Garcia focuses her practice on intellectual property litigation. She counsels prominent technology companies involved in global patent disputes and assists clients with patent litigation in federal district courts and in Section 337 investigations before the United States International Trade Commission. These disputes involve a variety of technologies, including smartphones, semiconductors and pharmaceuticals.

Ms. Garcia is also committed to pro bono work. She represented terminally-ill patients in a successful intervention to a challenge of Vermont’s law authorizing medical aid in dying. Ms. Garcia has also filed briefing regarding the dangers of solitary confinement on prisoners with mental disabilities in the Court of Appeals for the First Circuit on behalf of amici curiae. 

While in law school, Ms. Garcia was a judicial extern for the Honorable Juan R. Torruella of the United States Court of Appeals for the First Circuit, as well as for the Honorable Thomas J. Whelan of the United States District Court for the Southern District of California.

Prior to law school, Ms. Garcia was an intern for United States Senator Dianne Feinstein in Senator Feinstein's Los Angeles office.


  • Selected for inclusion in Best Lawyers: Ones to Watch for commercial litigation (2024). 
  • Named to Boston Magazine’s Top Lawyers list in 2023 in the area of intellectual property rights.

Insights & News


  • Education

    • JD, Boston University School of Law, 2015

      cum laude Third Year Editor, American Journal of Law and Medicine
    • BA, Political Science, University of California, Los Angeles, 2011

      minor in Global Studies
  • Admissions

    • Massachusetts

  • Languages

    • Spanish



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.